Thalassaemia: nyitott vizsgálatok itt: Görögország

• NCT07506863

  A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

  Kísérleti kezelés · 3. fázis · Agios Pharmaceuticals, Inc.

  Nosokomeio Paidon I Agia Sofia, Athens · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Regiszter frissítve: 2026-10-29

• NCT07517133

  A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia

  Kísérleti kezelés · 3. fázis · Agios Pharmaceuticals, Inc.

  Nosokomeio Paidon I Agia Sofia, Athens

  Regiszter frissítve: 2026-10-28

• NCT06609226

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Kísérleti kezelés · 3. fázis · Novo Nordisk A/S

  Hippokration Hospital, Athens · General Hospital Of Larissa Koutlibaneio And Triantafylleio, Larissa · General University Hospital Of Patras, Patras · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Regiszter frissítve: 2026-09-18

• NCT04143724

  Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

  Kísérleti kezelés · 2. fázis · Celgene

  Nosokomeio Paidon I Agia Sofia, Athens

  Regiszter frissítve: 2026-07-10

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Kísérleti kezelés · 3. fázis · Celgene

  Aghia Sophia' Children's General Hospital of Athens, Athens · Athens · Athens · Rio Patras · Thessaloniki

  Regiszter frissítve: 2026-07-01

• NCT07055503

  Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

  Kutatás · University Research Institute for the Study of Genetic & Malignant Disorders in Childhood

  Aghia Sophia' Children's Hospital, Athens

  Regiszter frissítve: 2025-12-17

• NCT05693909

  A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

  Kísérleti kezelés · 2. fázis · Pharmacosmos A/S

  Nosokomeio Paidon I Agia Sofia, Athens · Laiko General Hospital of Athens, Athens · Hippokration Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · General Hospital Of Larissa Koutlibaneio And Triantafylleio, Larissa · Olympion Therapeftirio General Clinic Of Patras S.A., Patra · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Regiszter frissítve: 2025-09-24

• NCT05799118

  Study of the Role of Genetic Modifiers in Hemoglobinopathies

  Kutatás · Cyprus Institute of Neurology and Genetics

  Laiko General Hospital, Athens · Hippokrateio Hospital of Athens, Athens · National and Kapodistrian University of Athens, Athens · General Hospital of Larissa, Larissa

  Regiszter frissítve: 2024-03-20

Minden vizsgálat (Thalassaemia) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek